Voxzogo: Treatment for Achondroplasia

The medicine Voxzogo is an Achondroplasia treatment. The medicine Voxzogo is sold under the brand name Vosoritide. This medicine is supplied in the single-dose vials in 0.4 mg, 0.56 mg, or 1.2 mg to administer subcutaneously. The active ingredient in the vials is Vosoritide with inactive ingredients trehalose dihydrate, mannitol, sodium citrate dihydrate, methionine, citric acid monohydrate, and polysorbate 80. Voxzogo contains vosoritide, a human C-type natriuretic peptide (CNP) analog. Vosoritide is a 39 amino acid peptide. Its amino acid sequence includes the 37 C terminal amino acids of the human CNP53 sequence plus Pro Gly on the N terminus to convey resistance to neutral endopeptidase (NEP) degradation. Vosoritide is manufactured from Escherichia coli using recombinant DNA technology.
Voxzogo is readily available with several certified generic medicine suppliers. For more detailed information about this medicine contact us on toll-free no. 18008891064.

Tweet